- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 16.44M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $10.37M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $4.58B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $14.69M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $13.25M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $14.83M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $84.02M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.17B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.71B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $180.47M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $213.79M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.07B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.07B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $184.84M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $175.52M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.08B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.15B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $16.85M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $58.7M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 16.16M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $30.54M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $49.72M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$33.40 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$33.40 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $34.86M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$539.69M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$486.44M |
| Revenue | Q1 2025 · Mar 31, 2024 | $234.51M |